Carl Marci, M.D., chief psychiatrist, managing director mental health & neuroscience, OM1

Most recent articles by Carl Marci, M.D., chief psychiatrist, managing director mental health & neuroscience, OM1

Using RWD and clinical narratives to generate commercial insights on discontinuation, treatment and prescribing patterns

Stefan P. Weiss, M.D., MHSc, MBA, managing director, dermatology, OM1

September 7, 2023

10:00 am

To improve outcomes, reduce healthcare costs, and improve commercial success of medications, a better understanding of why patients stop taking and providers stop prescribing a particular medication is needed.

From Our Partners

Partner Content

Will pharma finally reach out to minorities before the government forces their hand?

Why must the pharma industry consistently be positioned as an opponent? The government should seek “win-win” situations rather than “victories over …” situations. We still have a long way to go.

Partner Content

3 reasons the point of care is key for improving medication adherence

To overcome adherence obstacles, support needs to begin the moment a prescription is written and continue throughout the patient journey.

Partner Content

Laser focus your strategy: Data-driven marketing for oncology and rare diseases

How to use audience data to take your targeting capabilities to the next level.

Partner Content

The transformative impact of telehealth and point-of-care on healthcare marketing

Delivering educational content where and when it matters most.

HAYMARKET MARKETING COMMUNICATIONS:

HAYMARKET MARKETING COMMUNICATIONS:

Quick Links

Carl Marci, M.D., chief psychiatrist, managing director mental health & neuroscience, OM1

Most recent articles by Carl Marci, M.D., chief psychiatrist, managing director mental health & neuroscience, OM1

Using RWD and clinical narratives to generate commercial insights on discontinuation, treatment and prescribing patterns

The MM+M Media Summit

From Our Partners

Partner Content

Will pharma finally reach out to minorities before the government forces their hand?

Partner Content

3 reasons the point of care is key for improving medication adherence

Partner Content

Laser focus your strategy: Data-driven marketing for oncology and rare diseases

Partner Content

The transformative impact of telehealth and point-of-care on healthcare marketing

Thank you for accessing MM+M.